Eurofarma Laboratórios S.A. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported net loss was BRL 77.07 million compared to net income of BRL 139.75 million a year ago. Basic loss per share from continuing operations was BRL 0.078 compared to basic earnings per share from continuing operations of BRL 0.16273 a year ago. Diluted loss per share from continuing operations was BRL 0.078 compared to diluted earnings per share from continuing operations of BRL 0.16273 a year ago.
For the six months, net income was BRL 246.73 million compared to BRL 450.44 million a year ago. Basic earnings per share from continuing operations was BRL 0.2498 compared to BRL 0.52454 a year ago. Diluted earnings per share from continuing operations was BRL 0.2498 compared to BRL 0.52454 a year ago.